Stem cell treatment for pressure sores and some diabetic foot ulcers
Part of Skin clinical trials.
This Phase 1 study tests whether injected stem cells can help wounds heal faster or better. It focuses on people with specific wound types and sizes, and checks safety and wound healing over weekly visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a Stage III pressure ulcer, and the wound is about 5 to 36 cc in volume
- You may also have a Stage 1 or 2 diabetic foot ulcer (any size), but not a more advanced diabetic foot wound
- You’re able to give consent (or have a person who can consent for you)
- You can return for weekly wound check visits
- You cannot be allergic to TISSEEL, Tegaderm, or silicon-containing products
- You should not need special wound surgery or machines right now (negative pressure wound therapy, amputation, or surgery at the wound)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This trial tests whether stem cells taken from your own fat tissue can help heal foot ulcers caused by diabetes. The cells are applied to the wound, and the goal is to see if they improve healing and are safe.
This trial studies a new treatment using stem cell-derived exosomes (tiny particles from stem cells) applied to the foot to see if it can help heal diabetic foot wounds. It aims to improve healing and reduce complications for people with diabetes who have foot issues.
This trial tests whether a stem cell product (Stempeucel®) can improve healing and safety for people with critical limb ischemia caused by peripheral artery disease. It is for patients who cannot have (or have already tried) procedures to reopen blocked leg arteries and who have a leg ulcer and low blood-flow measurements.
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
This study tests whether stem cells taken from donated fat tissue are safe to inject into people with severe leg circulation problems (critical limb ischemia). It aims to see if the treatment is well tolerated and may help improve blood flow and reduce pain.
Hear when a new Pressure Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.